$GTCH
GBT Technologies Inc. Stock $gtch

$gtch Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000173112223000998 Filed on May 22, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$217.8K	$270.0K
YoY Change	-19.33%	499.93%
Cost Of Revenue	$176.1K	$209.0K
YoY Change	-15.74%
Gross Profit	$41.69K	$60.98K
YoY Change	-31.63%	35.51%
Gross Profit Margin	19.14%	22.59%
Selling, General & Admin	$204.3K	$1.006M
YoY Change	-79.7%	19.77%
% of Gross Profit	490.0%	1650.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$498.2K	$1.006M
YoY Change	-50.49%	19.77%
Operating Profit	-$456.5K	-$945.4K
YoY Change	-51.71%	18.88%
Interest Expense	$1.596M	$4.871M
YoY Change	-67.24%	-199.8%
% of Operating Profit
Other Income/Expense, Net	-$5.173M	$1.060K
YoY Change	-488135.66%	-99.65%
Pretax Income	-$5.630M	$3.926M
YoY Change	-243.39%	-173.04%
Income Tax
% Of Pretax Income
Net Earnings	-$5.630M	$3.926M
YoY Change	-243.39%	-173.04%
Net Earnings / Revenue	-2584.99%	1454.32%
Basic Earnings Per Share	$0.00	$0.12
Diluted Earnings Per Share	$0.00	$46.32K
COMMON SHARES
Basic Shares Outstanding	2.382B shares	33.39M shares
Diluted Shares Outstanding	25.71B shares	84.77M shares

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$66.72K	$278.6K
YoY Change	-76.05%	-84.76%
Cash & Equivalents	$59.07K	$496.8K
Short-Term Investments	$7.650K	$110.0K
Other Short-Term Assets	$556.00	$383.1K
YoY Change	-99.85%
Inventory	$7.567K	$29.37K
Prepaid Expenses
Receivables	$40.65K	$82.96K
Other Receivables	$193.8K	$0.00
Total Short-Term Assets	$381.5K	$774.0K
YoY Change	-50.71%	-74.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$556.00
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change		-100.0%
TOTAL ASSETS
Total Short-Term Assets	$381.5K	$774.0K
Total Long-Term Assets	$0.00	$0.00
Total Assets	$381.5K	$774.0K
YoY Change	-50.71%	-83.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.619M	$1.173M
YoY Change	38.01%	51.78%
Accrued Expenses	$367.7K	$7.520M
YoY Change	-95.11%	21.21%
Deferred Revenue	$38.94K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.004M	$11.01M
YoY Change	-36.4%	-19.94%
Total Short-Term Liabilities	$23.10M	$25.08M
YoY Change	-7.92%	-0.86%
LONG-TERM LIABILITIES
Long-Term Debt	$945.5K	$373.1K
YoY Change	153.39%	152.96%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$945.5K	$373.1K
YoY Change	153.39%	152.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.10M	$25.08M
Total Long-Term Liabilities	$945.5K	$373.1K
Total Liabilities	$24.04M	$25.46M
YoY Change	-5.56%	0.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$304.9M
YoY Change
Common Stock	$29.30K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$643.1K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$23.66M	-$24.68M
YoY Change
Total Liabilities & Shareholders Equity	$381.5K	$774.0K
YoY Change	-50.71%	-83.97%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$5.630M	$3.926M
YoY Change	-243.39%	-173.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$112.6K	$244.2K
YoY Change	-146.12%	-153.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$125.0K
YoY Change	-100.0%
Cash From Investing Activities		-$125.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$65.06K	222.4K
YoY Change	-70.75%	-50.08%
NET CHANGE
Cash From Operating Activities	-$112.6K	244.2K
Cash From Investing Activities		-125.0K
Cash From Financing Activities	$65.06K	222.4K
Net Change In Cash	-$47.57K	341.7K
YoY Change	-113.92%
FREE CASH FLOW
Cash From Operating Activities	-$112.6K	$244.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001471781
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Unearned Premiums UnearnedPremiums		usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	gtch	Revenue From Related Party RevenueFromRelatedParty		usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	gtch	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts		usd
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	gtch	Increase Decrease In Cash Held In Trust IncreaseDecreaseInCashHeldInTrust		usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2023Q1	gtch	Cash Paid For Investment To Tghi CashPaidForInvestmentToTghi		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash		usd
CY2023Q1	us-gaap	Interest Paid InterestPaid		usd
CY2022Q1	us-gaap	Interest Paid InterestPaid		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	gtch	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt		usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2022Q4	gtch	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion		usd
CY2023Q1	gtch	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable		usd
CY2022Q4	gtch	Unamortized Debt Discount At Convertible Note Payable UnamortizedDebtDiscountAtConvertibleNotePayable		usd
CY2022Q4	gtch	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	gtch	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent		usd
CY2023Q1	gtch	Current Portion Of Notes Payables CurrentPortionOfNotesPayables		usd
CY2023Q1	gtch	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents		usd
CY2022Q4	gtch	Debt Instruments Unamortized Discount Currents DebtInstrumentsUnamortizedDiscountCurrents		usd
CY2023Q1	gtch	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	gtch	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2022Q4	gtch	Due To Related Party Current DueToRelatedPartyCurrent	62003	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6524972	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-54530
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	GBT TECHNOLOGIES INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0603137
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2450 Colorado Ave.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100E
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Monica
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90404
CY2023Q1	dei	City Area Code CityAreaCode	888
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	685-7336
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4577753886	shares
CY2023Q1	us-gaap	Cash Cash	59067	usd
CY2022Q4	us-gaap	Cash Cash	106639	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40651	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25244	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	7567	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	11569	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	72222	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12500	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	193788	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	198475	usd
CY2023Q1	gtch	Investment Current InvestmentCurrent	7652	usd
CY2022Q4	gtch	Investment Current InvestmentCurrent	16198	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	556	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	381503	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	370625	usd
CY2023Q1	us-gaap	Assets Assets	381503	usd
CY2022Q4	us-gaap	Assets Assets	370625	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5376935	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6240634	usd
CY2023Q1	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	48921	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	38944	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	41444	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	6114140	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	6397727	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	750000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	116605	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	41137	usd
CY2023Q1	gtch	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2022Q4	gtch	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2023Q1	gtch	Due To Related Party Current DueToRelatedPartyCurrent	61809	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1714143	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	23096857	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18892671	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	516606	usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	75000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	353891	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	308863	usd
CY2023Q1	us-gaap	Liabilities Liabilities	24042354	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19201534	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2930101819	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2930101819	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1535593440	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1535593440	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	29301	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	15356	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	21	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	21	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2023Q1	gtch	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2022Q4	gtch	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	289450684	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288664858	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-304887630	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-299257917	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-23660851	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-18830909	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	381503	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	370625	usd
CY2023Q1	gtch	Sales Sales	217785	usd
CY2022Q1	gtch	Sales Sales	224970	usd
CY2022Q1	gtch	Revenue From Related Party RevenueFromRelatedParty	45000	usd
CY2023Q1	us-gaap	Revenues Revenues	217785	usd
CY2022Q1	us-gaap	Revenues Revenues	269970	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	176091	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	208987	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	41694	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	60983	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	149401	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	129383	usd
CY2023Q1	us-gaap	Marketing Expense MarketingExpense	54898	usd
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	341132	usd
CY2023Q1	us-gaap	Acquisition Costs AcquisitionCosts	293930	usd
CY2022Q1	us-gaap	Acquisition Costs AcquisitionCosts	535887	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	498229	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1006402	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-456535	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-945419	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	147628	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	68485	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-3924247	usd
CY2022Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	5239579	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1595650	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	235493	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	6031	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
CY2023Q1	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	8547	usd
CY2022Q1	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	65000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	193628	usd
CY2022Q1	us-gaap	Other Income OtherIncome	1057	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5173178	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4871658	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5629713	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3926239	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5629713	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3926239	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5629713	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3926239	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2381753489	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33387530	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25705601964	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84767611	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-18830909	usd
CY2023Q1	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	403548	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	316223	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-5629713	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-23660851	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-28761981	usd
CY2022Q1	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	35000	usd
CY2022Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	49504	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	68308	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59067	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	496760	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3926239	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-24682930	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5629713	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3926239	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	147628	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	68486	usd
CY2023Q1	gtch	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	3924246	usd
CY2022Q1	gtch	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-5239579	usd
CY2023Q1	gtch	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	1376302	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	80000	usd
CY2023Q1	gtch	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	8546	usd
CY2022Q1	gtch	Change In Fair Value Of Marketable Security ChangeInFairValueOfMarketableSecurity	65000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	315297	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15407	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	82964	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-4687	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3750000	usd
CY2022Q1	gtch	Increase Decrease In Cash Held In Trust IncreaseDecreaseInCashHeldInTrust	58002	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	59722	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	556	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4002	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29367	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-48921	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-225	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2500	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1056	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	414070	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2270304	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112635	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	244232	usd
CY2022Q1	gtch	Cash Paid For Investment To Tghi CashPaidForInvestmentToTghi	125000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	104300	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	68306	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	302700	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	182618	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	39043	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	302506	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	336734	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65063	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	222422	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-47572	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	341654	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106639	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155106	usd
CY2023Q1	gtch	Cash Equivalent At Carrying Value CashEquivalentAtCarryingValue	-59067	usd
CY2022Q1	gtch	Cash Equivalent At Carrying Value CashEquivalentAtCarryingValue	113616	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	383144	usd
CY2023Q1	gtch	Total Cash And Restricted Cash TotalCashAndRestrictedCash	-59067	usd
CY2022Q1	gtch	Total Cash And Restricted Cash TotalCashAndRestrictedCash	496760	usd
CY2023Q1	gtch	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	104301	usd
CY2023Q1	gtch	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	316223	usd
CY2022Q1	gtch	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	49504	usd
CY2023Q1	gtch	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	403548	usd
CY2022Q1	gtch	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	35000	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-500
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-304887630	usd
CY2023Q1	gtch	Working Capital Deficit WorkingCapitalDeficit	22715354	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zeHZaPhvT6pe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_zGWgXdd9He47">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4	gtch	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	1714143	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	0	usd
CY2023Q1	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zEAhmvfu5jvi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zClSXrYBUpF2">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of March 31, 2023 and December 31, 2022, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	gtch	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	6524972	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	48921	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	38944	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41444	usd
CY2022Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	200000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	56807	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40651	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	7567	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	556	usd
CY2023Q1	gtch	Asset Current AssetCurrent	105581	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	143700	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	93581	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	11569	usd
CY2022Q4	gtch	Due From Related Parties Currents DueFromRelatedPartiesCurrents	20270	usd
CY2022Q4	gtch	Asset Current AssetCurrent	125420	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	94496	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	23322777667	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3949223831	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	23322914137	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3949360301	shares
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.01
CY2023Q1	gtch	Escrow Amount Received EscrowAmountReceived	1000000	usd
CY2023Q1	gtch	Convertible Note Payable Description ConvertibleNotePayableDescription	IGOR 1 converted $232,575 of the convertible note into 733,235,294 shares of the Company’s common stock.
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	59408	usd
CY2023Q1	gtch	Final Settlement Agreement Description FinalSettlementAgreementDescription	SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	4200000	usd
CY2022Q1	gtch	Settlement Amount SettlementAmount	3750000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3750000	usd
CY2019Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4006	shares
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	7610147	usd
CY2019Q1	gtch	Annual Payment AnnualPayment	375000	usd
CY2019Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	93750	usd
CY2019Q1	gtch	Decrease In Capital DecreaseInCapital	5000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4006	shares
CY2021Q4	gtch	Services Payable ServicesPayable	33333	usd
CY2020Q1	gtch	Impairment Charge ImpairmentCharge	5500000	usd
CY2021Q4	gtch	Impairment Charge ImpairmentCharge	15400000	usd
CY2023Q1	us-gaap	Investments Investments	0	usd
CY2022Q4	us-gaap	Investments Investments	0	usd
CY2023Q1	gtch	Original Issue Discounts OriginalIssueDiscounts	6258	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	53150	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-06-01
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	7128	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	6654	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1619318	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1530762	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	367687	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1513261	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3389930	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3196611	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5376935	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6240634	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	48921	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	6738750	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	6586788	usd
CY2023Q1	gtch	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-108004	usd
CY2022Q4	gtch	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-189060	usd
CY2023Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6630746	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6397727	usd
CY2023Q1	gtch	Less Current Portion LessCurrentPortion	-6114140	usd
CY2022Q4	gtch	Less Current Portion LessCurrentPortion	-6397727	usd
CY2023Q1	gtch	Convertible Notes Payable Longterm Portion ConvertibleNotesPayableLongtermPortion	516606	usd
CY2022	gtch	Charge Related To Modification Of Debt ChargeRelatedToModificationOfDebt	13777480	usd
CY2023Q1	gtch	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	825000	usd
CY2022Q4	gtch	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	116605	usd
CY2023Q1	gtch	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	825000	usd
CY2022Q4	gtch	Other Convertible Notes Payable Current OtherConvertibleNotesPayableCurrent	116605	usd
CY2023Q1	gtch	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-75000	usd
CY2022Q4	gtch	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-116605	usd
CY2023Q1	gtch	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion	750000	usd
CY2023Q1	gtch	Total Notes Payables TotalNotesPayables	409408	usd
CY2022Q4	gtch	Total Notes Payables TotalNotesPayables	350000	usd
CY2023Q1	gtch	Debt Instruments Unamortized Discount Current DebtInstrumentsUnamortizedDiscountCurrent	-55517	usd
CY2023Q1	gtch	Note Payables NotePayables	353891	usd
CY2022Q4	gtch	Note Payables NotePayables	350000	usd
CY2022Q4	gtch	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-41137	usd
CY2023Q1	gtch	Long Term Note Payables LongTermNotePayables	353891	usd
CY2022Q4	gtch	Long Term Note Payables LongTermNotePayables	308863	usd
CY2023Q1	gtch	Schedule Of Note Payable Related Parties Table Textblock ScheduleOfNotePayableRelatedPartiesTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zgXZ3FexuCd9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8B0_zk65hP7RmCUg" style="display: none">Schedule of notes payable related parties</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td> </td> <td colspan="3" style="text-align: center"><span style="font-size: 10pt">March 31,</span></td> <td> </td> <td colspan="3" style="text-align: center"><span style="font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">2023</span></td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">2022</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; width: 58%; text-indent: -10pt"><span style="font-size: 10pt">Alpha Eda note payable</span></td> <td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_987_ecustom--TotalNotesPayableRelatedParty_c20230331__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: black 1pt solid; width: 11%; text-align: right" title="Total notes payable"><span style="font-size: 10pt">140,000</span></td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid; width: 1%"><span style="font-size: 10pt">$</span></td> <td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20221231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: black 1pt solid; width: 11%; text-align: right" title="Total notes payable"><span style="font-size: 10pt">140,000</span></td> <td style="width: 1%; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-size: 10pt">Total notes payable, related party</span></td> <td> </td> <td> </td> <td id="xdx_989_ecustom--TotalNotesPayableRelatedParties_c20230331_pp0p0" style="text-align: right" title="Total notes payable"><span style="font-size: 10pt">140,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--TotalNotesPayableRelatedParties_c20221231_pp0p0" style="text-align: right" title="Total notes payable"><span style="font-size: 10pt">140,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-size: 10pt">Unamortized debt discount</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_987_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_c20230331_zRCRrTEFg3Ye" style="border-bottom: black 1pt solid; text-align: right" title="Unamortized debt discount"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1248">—</span></span></td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98A_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_c20221231_zdwQgod8Q6mh" style="border-bottom: black 1pt solid; text-align: right" title="Unamortized debt discount"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1250">—</span></span></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-size: 10pt">Notes payable, net, related party</span></td> <td> </td> <td> </td> <td id="xdx_98F_ecustom--NotesPayableRelatedParties_c20230331_pp0p0" style="text-align: right" title="Notes payable"><span style="font-size: 10pt">140,000</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98C_ecustom--NotesPayableRelatedParties_c20221231_pp0p0" style="text-align: right" title="Notes payable"><span style="font-size: 10pt">140,000</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-size: 10pt">Less current portion</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_ecustom--CurrentPortionOfNotePayableRelatedParties_c20230331_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Less current portion"><span style="font-size: 10pt">(140,000</span></td> <td style="padding-bottom: 1pt"><span style="font-size: 10pt">)</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_c20221231_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Less current portion"><span style="font-size: 10pt">(140,000</span></td> <td style="padding-bottom: 1pt"><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-size: 10pt">Notes payable, net, related party, long-term portion</span></td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_98D_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20230331_pdp0" style="border-bottom: black 2.25pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1260">—</span></span></td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_983_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20221231_pdp0" style="border-bottom: black 2.25pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1262">—</span></span></td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>
CY2023Q1	gtch	Total Notes Payable Related Parties TotalNotesPayableRelatedParties	140000	usd
CY2022Q4	gtch	Total Notes Payable Related Parties TotalNotesPayableRelatedParties	140000	usd
CY2023Q1	gtch	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2022Q4	gtch	Notes Payable Related Parties NotesPayableRelatedParties	140000	usd
CY2023Q1	gtch	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2022Q4	gtch	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2023Q1	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q4	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.0004
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.001
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	10192485	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	325915	usd
CY2022	gtch	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	-2209887	usd
CY2022	gtch	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	-6594370	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1714143	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	1202806	usd
CY2023Q1	gtch	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	-316223	usd
CY2023Q1	gtch	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	3924247	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	6524972	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1294508379	shares
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	390603	usd
CY2023Q1	gtch	Debt Conversion Converted Instrument Accrued Interest DebtConversionConvertedInstrumentAccruedInterest	15268	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	369198	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	35000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	70770	shares
CY2023Q1	gtch	Weighted Average Exercise Price Warrants Outstanding Beginning WeightedAverageExercisePriceWarrantsOutstandingBeginning	205.07
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	60100	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10670	shares
CY2023Q1	gtch	Weighted Average Exercise Price Warrants Outstanding End WeightedAverageExercisePriceWarrantsOutstandingEnd	729.90
CY2023Q1	gtch	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1	P0Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	10670	shares
CY2023Q1	gtch	Weighted Average Exercise Price Warrants Exercisable At End WeightedAverageExercisePriceWarrantsExercisableAtEnd	729.90
CY2023Q1	gtch	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms	P0Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10670	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	10670	shares
CY2023Q1	gtch	Compensated With Additional Shares CompensatedWithAdditionalShares	200000000	shares
CY2023Q1	gtch	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2022Q4	gtch	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	140000	usd
CY2020Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	48844	usd
CY2020Q3	gtch	Legal Cost LegalCost	716	usd
CY2020Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	48844	usd
CY2020Q4	gtch	Legal Cost LegalCost	716	usd
CY2021Q3	gtch	Cancellation Of Payments CancellationOfPayments	5000	usd
CY2023Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_80E_eus-gaap--LossContingencyDisclosures_z73yCu32znv" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 17 - <span id="xdx_823_zHH4keOWOfp1">Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_90E_eus-gaap--Revenues_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_pp0p0" title="Revenues">300,000</span> which is nonrefundable. The Company recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_901_ecustom--PaymentForExpenses_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_pp0p0" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_907_eus-gaap--DeferredRevenue_c20230331__dei--LegalEntityAxis__custom--GBTTechnologiesMember_pp0p0" title="Unearned revenue">200,000</span> to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190101__20190108_zNZnET0RNFed" title="Restricted shares">4,006</span> restricted shares of its common stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20190101__20190108_z2CThVvhWBQ9" title="Value of restricted shares">7,610,147</span> (based on the closing price on the grant date) for three years for an annual payment of $<span id="xdx_90A_ecustom--AnnualPayment_iI_c20190108_zV2iyyRhEN5j" title="Annual payment">375,000</span> paid in quarterly installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20190101__20190108_zQ53hNT4g7Nc" title="Installment paid">93,750</span>. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $<span id="xdx_90C_ecustom--DecreaseInCapital_c20190101__20190108_z1cke1tVsuve" title="Decrease in capital">5,000,000</span>, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20230101__20230331_zJmPO3GduZ3l" title="Restricted shares">4,006</span> restricted shares have not yet been returned to the Company as of March 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Assignment of lease agreement</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $<span id="xdx_905_eus-gaap--OperatingExpenses_c20220501__20220517_zOh2kfmYfHr8" title="Operating expense">200</span> per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"> On June 10, 2022, GBT Technologies, Inc. (the “Company”), entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.2pt 0 0; text-align: justify; background-color: white">Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute <span id="xdx_900_eus-gaap--SharesIssued_iI_c20230331__dei--LegalEntityAxis__custom--GBTMember_zoocNWSapYE" title="Share issued">500,000,000</span> shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.2pt 0 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $25,000 per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The closing of the Metaverse Agreement occurred on June 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $5,000 to the Company as settlement payment and surrender their shares in Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2012 for 24 consecutive months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p>
CY2019Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4006	shares
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	7610147	usd
CY2019Q1	gtch	Annual Payment AnnualPayment	375000	usd
CY2019Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	93750	usd
CY2019Q1	gtch	Decrease In Capital DecreaseInCapital	5000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4006	shares
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	200	usd

Files In Submission

Name	View Source	Status
gtch-20230331_def.xml	Edgar Link	unprocessable
0001731122-23-000998-index-headers.html	Edgar Link	pending
0001731122-23-000998-index.html	Edgar Link	pending
0001731122-23-000998.txt	Edgar Link	pending
0001731122-23-000998-xbrl.zip	Edgar Link	pending
e4727_10-q.htm	Edgar Link	pending
e4727_ex31-1.htm	Edgar Link	pending
e4727_ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gtch-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gtch-20230331_cal.xml	Edgar Link	unprocessable
e4727_10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
gtch-20230331_lab.xml	Edgar Link	unprocessable
gtch-20230331_pre.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTCH
GBT Technologies Inc. Stock $gtch

2023 Q1 Form 10-Q Financial Statement

#000173112223000998 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH GBT Technologies Inc. Stock $gtch

2023 Q1 Form 10-Q Financial Statement

#000173112223000998 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH
GBT Technologies Inc. Stock $gtch